Directory
>
Scott Mitchell
Scott Mitchell
Vice President of Chemistry at Enanta Pharmaceuticals | Enanta Pharmaceuticals
Watertown, Massachusetts, United States
Scott Mitchell
Summary
Scott Mitchell is an accomplished Vice President of Chemistry at Enanta Pharmaceuticals with a robust background in pharmaceutical research and drug discovery. With over three decades of experience in the industry, he has held significant roles at leading companies like Gilead Sciences and Novartis, where he contributed to small molecule drug discovery and oncology research. Scott's academic foundation includes a Ph.D. in Organic Chemistry from the University of Arizona, complemented by a Bachelor's degree in Biochemistry from Trinity College-Hartford. His leadership experience is marked by his tenure as Senior Director and Principal Scientist, showcasing his ability to drive innovation and manage complex projects. Known for his collaboration with notable figures, including a Nobel Laureate, Scott possesses a unique blend of scientific expertise and strategic vision. His commitment to advancing pharmaceutical science is evident in his ongoing role at Enanta Pharmaceuticals, where he continues to influence the development of new therapies.
Scott Mitchell
Work Experience
Vice President of Chemistry at Enanta Pharmaceuticals at
Enanta Pharmaceuticals
August 2022 - Present
Vice President of Chemistry at
Enanta Pharmaceuticals
August 2022 - Present
Senior Research Scientist II at
Gilead Sciences
July 2010 - August 2022
Vice President of Chemistry at
Silverback Therapeutics
April 2021 - August 2022
Principal Scientist at
Gilead Sciences
December 2018 - April 2021
Senior Director at
Gilead Sciences
January 2020 - April 2021
Senior Research Fellow at
CGI Pharmaceuticals, Inc.
November 2002 - July 2010
Senior Scientist II at
Neurogen Corporation
May 2000 - November 2002
Senior Research Scientist at
Johnson Matthey
June 1999 - May 2000
Graduate Student at
The University of Arizona Department of Chemistry and Biochemistry
January 1994 - January 1999
Research Scientist at
Novartis
May 1992 - July 1994
Research Scientist at
Rockefeller University
July 1989 - July 1992
Scott Mitchell
Education
The University of Arizona, Ph.D.
January 1994 - January 1999
January 1985 - January 1989
Frequently Asked Questions about Scott Mitchell
What is Scott Mitchell email address?
Scott Mitchell's primary email address is *********@silverbacktx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Scott Mitchell work for?
Scott Mitchell is a Vice President of Chemistry at Enanta Pharmaceuticals at Enanta Pharmaceuticals, a company specializing in Commercial physical research.
Where Scott Mitchell graduated from?
Scott Mitchell holds a degree in Organic Chemistry from The University of Arizona.
How can I directly contact Scott Mitchell?
To contact Scott Mitchell directly, you can use the email address *********@silverbacktx.com. Complete contact information is available upon registration with Muraena.
Who is Scott Mitchell?
Scott Mitchell is an accomplished Vice President of Chemistry at Enanta Pharmaceuticals with a robust background in pharmaceutical research and drug discovery. With over three decades of experience in the industry, he has held significant roles at leading companies like Gilead Sciences and Novartis, where he contributed to small molecule drug discovery and oncology research. Scott's academic foundation includes a Ph.D. in Organic Chemistry from the University of Arizona, complemented by a Bachelor's degree in Biochemistry from Trinity College-Hartford. His leadership experience is marked by his tenure as Senior Director and Principal Scientist, showcasing his ability to drive innovation and manage complex projects. Known for his collaboration with notable figures, including a Nobel Laureate, Scott possesses a unique blend of scientific expertise and strategic vision. His commitment to advancing pharmaceutical science is evident in his ongoing role at Enanta Pharmaceuticals, where he continues to influence the development of new therapies.
Scott`s contact details
*********@silverbacktx.com
***********@stny.rr.com
**************@gilead.com
*********@enanta.com
Colleagues
Chief Financial Officer
Vice President, CMC
Chief Business Officer
Chief Product Strategy Officer
Vice President, DMPK & Bioanalysis
Chief Medical Officer
Executive Director, Contracts Administration
Executive Director of Accounting, Controller
Vice President, Toxicology
Vice President of DMPK and Bioanalysis